ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IQAI Iq-ai Limited

1.60
-0.10 (-5.88%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Iq-ai Limited LSE:IQAI London Ordinary Share JE00BD4H0R42 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -5.88% 1.60 1.50 1.70 1.65 1.60 1.65 282,548 12:02:40
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Florists 536k -512k -0.0028 -5.71 2.92M
Iq-ai Limited is listed in the Florists sector of the London Stock Exchange with ticker IQAI. The last closing price for Iq-ai was 1.70p. Over the last year, Iq-ai shares have traded in a share price range of 1.285p to 5.75p.

Iq-ai currently has 182,621,390 shares in issue. The market capitalisation of Iq-ai is £2.92 million. Iq-ai has a price to earnings ratio (PE ratio) of -5.71.

Iq-ai Share Discussion Threads

Showing 251 to 269 of 9075 messages
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
07/6/2019
13:49
What is far more important is what happens to IQAI (the business and the share price) after the imminent FDA approval for IQAI's StoneChecker software: which should be announced this month, and could be any day.

The fact that FDA approval has taken so long shows how rigorous the process is, how advanced the product is, and also what a great achievement approval will be.
And one that will be monumental for IQAI's development, because America is such a vast and well-funded healthcare market, which is at the forefront of applying new technology.

This won't therefore be your 'average' good news: it will be gold-plated, company-transformative, 'talk of the town' news.

Therefore, I think that we can expect a very big immediate rerating upwards in the share price ... but that should be just for starters.
The general upward momentum could continue for weeks, months, and years.

And in terms of business, IQAI is chaffing at the bit to start selling StoneChecker into the multi trillion dollar US healthcare market, and has been investing into its business ahead of that, a very positive sign.

IQAI also appears to have a range of potential US reseller agreements lined up, which could be ready for signing once FDA marketing approval is received. -

08/02/2019 10:29 UKREG IQ-AI Limited Business Update
"...Meanwhile IQ-AI continues to seek business development relationships that will expose its products to a broader audience worldwide. Several marketing and distribution alliances are under active consideration. These will be evaluated, and if appropriate, will be announced in the next few months...."


30/04/2019 12:00 UKREG IQ-AI Limited Publication of Annual Report
"... The Company will focus on four areas of revenue development in 2019:
1. Sales development of existing products
During 2018, the Company sold or trialled software at many of the United States' most well-regarded hospitals and specialist clinics. IB Neuro remains the only 'biopsy confirmed' neuro perfusion software available on the market. Publicising this to all potential users is a key element of the Company's 2019 plans. We also intend to explore collaborative business relationships where our sales reach can be expanded by encouraging other companies' sales teams to promote our product for financial reward. This work is already underway with a series of resellers such as aycan Medical Systems, QMENTA, Blackford and Medimsight. ..."


All this bodes well for a period of very positive IQAI newsflow in the near future, driving the share price to much higher levels ahead of the next fundraising.

hedgehog 100
07/6/2019
13:22
The rest of you points, LR2, are largely irrelevant fluff: a collection of 'nothing' trying to be 'something'.

And ones that you have generally been droning on about relentlessly, and have been discussed before.

I could come up with a far more negatively impressive list for virtually any penny share, if I was prepared to waste my time the way you do.

But here are a few brief observations regarding your points:

• Until mid 2017 Flying Brands was a shell, with no operations.
• Stone Checker Software (SCS) reversed into Flying Brands because FBDU was a shell needing a business, and SCS was a business needing a shell.
• The 4 million FBDU shares issued to acquire SCS are worth under £50K. at the current share price, for a business that could be worth tens of millions. Not surprisingly, FBDU shareholders voted massively in favour of it.
• RNS corrections are commonplace, and in IQAI's case the mistake was benign ... probably caused by a late change in the share price.
• The overall trend in revenues IS accelerating.
• There is no conflict of interest.

hedgehog 100
07/6/2019
12:49
LR2 6 Jun '19 - 21:05 - 246 of 246
"Nice try picking out two NED positions held by Trevor Brown and then make a massive assumption that the share price of the company in each case reflected on Trevor being there.
In case you forgot, a “non-executive” director is merely a director who is NOT involved in the day-to-day management of the company. ..."


LR2,

Once again you're being dishonest.

I didn't "pick out" two directorships: those were his LAST TWO directorships prior to IQAI (Flying Brands), and that is a simple statement of fact.

If those share prices had gone down massively during his directorships, you would be the first to complain about it.
If you've got any knowledge of a fallen share price during a prior TB directorship (which I don't think you have), then post it, instead of making an insinuating smear.

And you are showing your ignorance of business and investment.

Often the key difference between the success or failure of a company is STRATEGY.
And that's where an experienced NED can be worth his weight in gold.

It's clear from the RNSes that Trevor Brown was key in the strategy development of both AVO and FDBK, to the huge benefit of both companies.

Moreover, he was also a strategic investor in both companies, just like at IQAI.


His business savvy is clearly extraordinary, and his judge of investments and investment timing top notch.
Coupled with a rare level of integrity (as shown by funding IQAI at a massive premium - and how many directors would do that), and what's not to like with him?

Would you please 'warn' me about any other director with a track record like his, as I would be very interested indeed!


And another similarity with IQAI is that TB isn't taking the day-to-day lead on operations here.
That's under the overall control of IQAI's August 2018 appointment David Smith, who sold his last company for $178M., and compared to the $22M. it raised from investors:
06/08/2018 07:00 UKRegulatory (RNS & others)


David Smith knows who to drive sales from zero to tens of millions of dollars, because he's been there before, and has stated his intention to do it here.


So with Trevor Brown overseeing strategy here, and David Smith overseeing operations, it looks like a perfect combination, and one with formidable potential to create something big here.

hedgehog 100
06/6/2019
21:05
Nice try picking out two NED positions held by Trevor Brown and then make a massive assumption that the share price of the company in each case reflected on Trevor being there.

In case you forgot, a “non-executive” director is merely a director who is NOT involved in the day-to-day management of the company.

Suggest you go back and do the same chart cut and paste on his last two CEO positions.

In the meantime perhaps you could advise why the IQAI directors pay went from £50,500 in 2017 to £125,000 in the 2018 accounts? What had they done to earn that pay rise?

Or why Trevor Brown said IQAI was fully funded until June '19 but ended up raising money in March '19?

Or why Trevor Brown said FDA clearance was expected by end December '18 but we are still waiting for it today?

Or why when Trevor Brown had already raised money in March '19 did he have to raise again two months later in May '19?

Or why was the mistake in 29th May '19 RNS not noticed by either Trevor Brown, the IQAI board, or Peterhouse? Too chummy perhaps?

Or why a Peterhouse Executive Director, Qu Li, sits on the 3 person board at IQAI? Do you not consider that a conflict of interest and the board designed to make Trevor Brown all powerful?

Or why in June '17 Trevor Brown sold Stone Checker Software Ltd to IQAI for 4,000,000 IQAI shares at a 3p per share valuation? Who benefited from that? Trevor Brown with another 4 million shares or IQAI shareholders who took on a company which had, at last count, assets of £1,628 and debts of £213,518.

Or why IQAI stated in their last accounts that revenue was accelerating but had revenue in the 1st half year of £126k and only revenue in the 2nd half year of £39k? How is £39k an acceleration from the previous £126k?

Or what each resolution passed at today's AGM was actually about? There you go HH, a simple one to end with.

lr2
06/6/2019
18:52
LR2 6 Jun '19 - 17:58 - 244 of 244
" ... You really don't like people who have an alternative viewpoint to yourself do you. ... "


LR2,

Look who's talking.

You had a relatively free run bashing IQAI until I started posting here just over a month ago.

Now finally you've encountered someone who's willing and able to stand up to your nonsense, and you don't like it one little bit.

And it's not your factual research I object to, it's your bonkers statements on the FDA approval, the fundraisings, and the company's sales, etc.

I'm always realistic about timescales, because decades of experience has taught me that slippage is par for the course.
Which makes it so laughable that you try to make out that it's 'lying' here that you need to 'warn' us about.
Why not issue some warnings about FDBK?


But the crux of your 'warnings' to us about TB is that he will cost us money, i.e. a poorly performing share price.

Well, let's "seek truth from facts" and examine his record shall we: the share price performance during his two previous listed directorships prior to here. -


1. ADVANCED ONCOTHERAPY (AVO) (formerly CareCapital): 28.6.12 - 30.8.13.

Share price rise from approx. 25p to approx. 92p: GAIN OF C. 268%.



28/06/2012 07:01 UK Regulatory (RNS & others) CareCapital Group plc Appointment of Director
"CareCapital (AIM: CARE) is pleased to announce the appointment of Trevor Brown as a Non-executive Director with immediate effect.
Trevor Brown (66) has been a strategic investor in real estate and equities for more than 30 years. Mr Brown is a director of Free Association Books Limited in London.
He has a beneficial interest as at the date of this announcement in 15,334,001 ordinary shares of CareCapital, representing 9.38% of the Company's current issued share capital.
There is no further information required to be disclosed in relation to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.
Commenting on the appointment, Dr Mike Sinclair, CareCapital's CEO, said, "I am pleased that Trevor has agreed to join the Board as a Non-executive Director. He is, and has been, a supporter of our plans to refocus CareCapital on the provision of advanced cancer treatment services. His experience and track record will greatly benefit our Board, our management team and our shareholders. I welcome him to CareCapital." ..."


30/08/2013 07:15 UK Regulatory (RNS & others) Advanced Oncotherapy PLC Directorate Change
" ...Advanced Oncotherapy announces that Non-Executive Director Trevor Brown has resigned from the Board for health reasons. Trevor became a director in June 2012 and has been, and remains, a significant investor in the Company and major supporter of its new cancer services strategy.
Advanced Oncotherapy's CEO, Dr Mike Sinclair, said, "Trevor was an early supporter of our change of strategy to become a cancer treatment services business. We benefited both from his advice during a time of transition and his investment in the Company. On behalf of the Board and all of our shareholders, I thank him for his involvement. We wish him a speedy return to good health."
Trevor Brown added, "I have enjoyed being a director of Advanced Oncotherapy and participating in the design and formulation of a strategy that I believe will yield substantial returns for shareholders. I remain a committed supporter of, and shareholder in, the Company and look forward to its continuing development and growth." ..."



2. FEEDBACK (FDBK): 13.1.14 - 8.6.17

Share price rise from approx. 0.85p to approx. 3.75p: GAIN OF C. 341%.



13/01/2014 08:00 UK Regulatory (RNS & others) Feedback PLC Directorate Change
"The Company announces that Trevor Brown and Tom Charlton have joined the board with immediate effect as Non-Executive Directors.
Mr Brown, aged 67, has been a strategic investor in real estate and equities for more than 30 years. He was most recently a director of Advanced Oncotherapy plc where he was involved in the strategy of transition to the provision of advanced cancer treatment services. …"


08/06/2017 13:11 UK Regulatory (RNS & others) Feedback PLC Directorate Change
"Feedback plc (AIM: FDBK), the medical imaging software company, announces that Trevor Brown, has resigned as a Non-Executive Director of Feedback, with immediate effect ...
Dr Alastair Riddell, Non-Executive Chairman, commented: "I should like to thank Trevor for his invaluable support of the Company following its readmission in 2014 which has enabled it to achieve substantial progress to date. ..."



= AVERAGE INCREASE OF c. 304.5%.


In summary, on the key metric of share price performance, Trevor Brown has really delivered the goods: an on average QUADRUPLING of these two share prices.

And of all the miserably under performing directors of penny shares, you choose to consistently 'warn' us of one of the very few consistent successes!


Now, why not tell us how massive your losses on Feedback are, and how you wish you'd traded it like Trevor Brown?

hedgehog 100
06/6/2019
17:58
As I said earlier, "You're funny". At least I can agree with you that "there is an enormous amount of garbage on the internet". You appear to have added more than your fair share.

And because IQAI have a number of investors that might welcome some research, I will give them the opportunity to see the facts as I find them. I don't want them left with just your point of view as all you do is suck up whatever IQAI throws out without question. Someone employed by TB couldn't do a better job of pushing the company viewpoint on these boards. Open your eyes and look beyond what they say.

You really don't like people who have an alternative viewpoint to yourself do you.

Do you belittle people in real life as you do here or are you just another keyboard warrior I wonder?

lr2
06/6/2019
17:51
LR2 clearly has a grudge against Trevor Brown, who he blames for a fall in the Feedback (FDBK) share price, since he resigned as a FDBK director two years ago. But is he really angry at TB, or angry at himself?
When TB resigned, the FDBK share price was nearly 4p; now it's 0.9p.

08/06/2017 13:11 UK Regulatory (RNS & others) Feedback PLC Directorate Change
"Feedback plc (AIM: FDBK), the medical imaging software company, announces that Trevor Brown, has resigned as a Non-Executive Director of Feedback, with immediate effect ...
Dr Alastair Riddell, Non-Executive Chairman, commented: "I should like to thank Trevor for his invaluable support of the Company following its readmission in 2014 which has enabled it to achieve substantial progress to date. ...
Trevor Brown, said: " ... I have indicated to the board that I am preparing to enter into an orderly market agreement in respect of my substantial shareholding ..." "


Over the eleven months following his resignation Trevor Brown gradually sold down his FDBK holding, passing below the 3% threshold just over a year ago:

10/05/2018 09:27 UK Regulatory (RNS & others) Feedback PLC Holding(s) in Company






I'm not saying that TB is an angel (and Even Warren Buffett has his critics), but he is a very successful businessman and investor.

FDBK generally performed very well over the period TB was a director there, but hasn't since he left.
And with FDBK, TB bought low and sold high.
And now with IQAI, TB is buying low again, and seems to be building something very exciting.
In my opinion it makes sense to follow a winner like TB.

In addition, IQAI is not just about TB, as we know.
Remember that IQAI's August 2018 appointment David Smith sold his last company for $178M., and compare that to the $22M. it raised from investors:
06/08/2018 07:00 UKRegulatory (RNS & others)


And that IQAI acquired US company Imaging Biometrics, complete with founding CEO, in March 2018. (For £440,000 in shares at 4p per share, and $68,134 cash.) -
13/03/2018 07:40 UK Regulatory (RNS & others) Flying Brands Limited Acquisition of


This has demonstrated Trevor Brown's company-building abilities at Flying Brands / IQAI in two major ways.

hedgehog 100
06/6/2019
16:48
Intersting LR2.

So if people posts links to Elon's Musk's allegations about the diver currently sueing him for libel, that 'proves' them does it?


And it follows that you MUST be a crook.
After all, people could post links to my posts about you on ADVFN, which 'proves' it!!

There is an enormous amount of stuff on the internet, some true and some not, but once something is out there, it stays out there.

You can't be as successful a businessman and investor as TB without annoying some people who aren't as successful as him (e.g. yourself).

But in any case, you have been campaigning about TB for YEARS.

Not just a quick, clean hit, and then moving on.

Apparently using these boards as a cheap alternative to therapy over your FDBK trauma!

And IQAI is not just about TB, and it has multiple other shareholders, so why should they be constantly punished?

hedgehog 100
06/6/2019
16:01
"Moving back to IQAI, it's the FDA & the US government shutdown that have let the IQAI down on timescales, which is not IQAI's fault."

In Trevor Brown's own words - "The target date for CE marking is December 2017 and for FDA approval is Q2 2018."

We're in Q2 2019 and you blame a US government shutdown. That's one hell of a shutdown. Does Donald Trump know?

"And as it's Trevor Brown's own money, you can best believe that it will be wisely used."

I won't argue with that. I'm sure he will find a way of coming out on top. Not so sure the other shareholders will though. Go research companies where he used to have a holding and see if the shareholders are happy with him.

"And with David Smith heading operations, we have someone who knows how to ramp up sales from nothing to tens of millions, as he's done it before, and has stated his intention to do it here."

Speculation. Time will tell whether his holding in AQAI will benefit him down the line.

lr2
06/6/2019
15:24
"But what most investors want to know is, will IQAI be successful as a business and as an investment."

And yet you don't like it when I post the downside to certain things TB says and does. As I said before, you only want posters who agree 100% with your point of view.

I can, and have, pointed out a number of occasions when I, as an outsider, had a considerably better point of view regarding company cash flow than the owners of this company. Funny how they can be wrong so often. They must be incredibly stupid or else they would be seriously misleading investors.

lr2
06/6/2019
15:15
LR2 6 Jun '19 - 14:44 - 233 of 235
"You're funny but still a nasty little liar. Oh, and you added nothing to my original links. All you did was cut and paste the original articles along with the links which simply deprives the commissioning web pages from obtaining clicks and benefiting from any advertising revenue. Nice going fella."


Yet another lie.

Anyone can see that I have just posted extracts from the articles (with ellipses), not the articles in full.

If anything, that makes readers more likely to visit the links concerned, if their interest is sparked.

And I will not take lessons in integrity from a monstrously market abusing troll.
YOU POST DISHONESTLY.
A few pennies more or less to a website, even if that was the case, is nothing compared to your disgusting lying and deception.


But let's cut to the chase here.

You are obsessively nit picking about TRIVIA, with both me and Trevor Brown.

But what most investors want to know is, will IQAI be successful as a business and as an investment.

You hope not because of your obsessive and unjustified grudge against Trevor Brown (which makes you a very sad little man), but because you don't have anything of substance you are having to flail around for irrelevant fluff.

hedgehog 100
06/6/2019
14:56
Not in your case.
lr2
06/6/2019
14:54
LR2,

Here's some original material from yourself ... fully acknowledged.

It's something that you said recently on the Feedback thread ... about yourself:

LR2 25 Mar '19 - 23:57 - 603 of 603 of 809
" ... Word of warning - I am often a poor judge of character..."

hedgehog 100
06/6/2019
14:44
You're funny but still a nasty little liar. Oh, and you added nothing to my original links. All you did was cut and paste the original articles along with the links which simply deprives the commissioning web pages from obtaining clicks and benefiting from any advertising revenue. Nice going fella.
lr2
06/6/2019
14:23
LR26 Jun '19 - 14:17 - 229 of 229
"You certainly didn't claim them as mine. ..."


As YOURS!

Did you write them?!!

Concentrate on your own problems mate, because you have enough of them.

In my opinion you need to see a shrink.

hedgehog 100
06/6/2019
14:17
You certainly didn't claim them as mine. Decent people acknowledge who made the original posts. You, on the other hand, were being deceitful about it. As such, you are the nasty little liar (by omission) not I.

I reserve the right to point out Trevor Brown's faults as well as yours.

lr2
06/6/2019
14:09
LR2 6 Jun '19 - 13:59 - 227 of 227
"I can't copy it as it was deleted.
As you were posting my links from this morning as your research I came back to admonish you. You shouldn't try and deceive people into believing you found the links. Your deception brought me back."


LR2,

What on earth are you talking about - are you insane?
No where do I claim that those articles are my own research.
Once again you have exposed yourself as a nasty little liar: maybe I will post the ever lengthening list.

You've been doing it to Trevor Brown for ages, and now you're doing it to me.

And now you say that there was just one post of Trevor Brown comments about TexRAD that you're complaining about, which wasn't even kept up!

And even that apparently was ages ago!

GET A LIFE!!

hedgehog 100
06/6/2019
13:59
I can't copy it as it was deleted.

As you were posting my links from this morning as your research I came back to admonish you. You shouldn't try and deceive people into believing you found the links. Your deception brought me back.

lr2
06/6/2019
13:50
LR2 1 Jun '19 - 18:39 - 206 of 225
" ... I will leave you alone for now assuming I am also left alone to post elsewhere.
Enjoy the peace and quiet."


LOL, well done LR2, you managed nearly five days!!

You said recently that Trevor Brown had made one post about FDBK in six months; well compare that to you recent IQAI attack rate of about twenty posts a month, on this website alone. Apparently you believe in 100 to one reprisals!

You also recently accused him of having multiple posting names, but not phonetically linked, to mislead people.
But apparently he had just two on ADVFN: Freddy, and ydderF , and not used at the same time.

And the irony is, most people here would never have found out about his commenting about TexRAD that you dislike, but for you constantly droning on about it!

But if you want to debate his comments, do so: copy and paste here exactly what he has said about TexRAD (and not just your own twisted spin on it), and say why you disagree with it.

hedgehog 100
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock